Clinical trials: Acute Biphenotypic Leukemia

AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome)

Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders

• Terminated
• Age: 3 to 45 years
• Phase 1
• Results posted

A significant number of patients with hematologic malignancies need a hematopoietic stem cell transplant (HSCT) to be cured. Only about 50% of these patients have a fully matched donor, the remaining patients will require an HSCT…

Conditions

AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia, NHL - Non-Hodgkin's Lymphoma

Trial name

T-allo10 (NCT03198234)

Testing

T-allo10

Where

United States

Volunteers

5 people

Sponsor

Roncarolo, Maria Grazia, MD